Compass Therapeutics General Counsel Executes Open Market Share Purchase
Jonathan Anderman, the General Counsel for Compass Therapeutics, Inc. (NASDAQ:CMPX), has expanded his holdings in the company through a direct purchase of common stock. The transaction, which took place on April 29, 2026, involved an acquisition of 25,000 shares via the open market at a price per share of $1.89. This move brings the total value of …